No difference in outcomes after 5 years with anti-ischemic metabolic agent in patients after PCI

3' education - Sep. 15, 2020 - Prof. Freek Verheugt - Amsterdam, The Netherlands

Educational information

This video was recorded during the ESC Congress 2020.

Faculty

Prof. Verheugt - cardiologist in Amsterdam, The Netherlands

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.